Allurar rigakafin zazzabi mai launin rawaya

Allurar rigakafin zazzabi mai launin rawaya
essential medicine (en) da vaccine type (en)
Bayanai
Ƙaramin ɓangare na	viral vaccines (en)
Vaccine for (en)	Cutar amai da gudawa
Medical condition treated (en)	Cutar amai da gudawa
Brand (en)	Stamaril (en) da YF-Vax (en)
NCI Thesaurus ID (en)	C96396

Allurar rigakafi zazzabi mai launin rawaya Ta kasance wata allurar rigakafi ce da ke karewa daga zazzabi.^[1] Yellow fever kamuwa da cuta ce da ke faruwa a Afirka da Kudancin Amurka.^[1] Yawancin mutane sun fara samun rigakafi a cikin kwanaki goma na allurar rigakafi kuma ana kare kashi 99% a cikin wata daya, kuma wannan ya bayyana dindindin.^[1] Ana iya amfani da allurar rigakafin domin hana barkewar cutar.^[1] Ana ba da shi ko dai ta hanyar allura a cikin tsoka ko kuma a ƙarƙashin fata.^[1][2]

Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar rigakafi na yau da kullun a duk ƙasashe inda cutar ta zama ruwan dare.^[1] Wannan yana faruwa ne a tsakanin watanni tara zuwa goma sha biyu.^[1] Wadanda ke tafiya zuwa wuraren da cutar ke faruwa domin yin rigakafi.^[1] Ba a buƙatar ƙarin allurai bayan na farko ba.^[3]

Allurar rigakafin zazzabi mai launin rawaya gabaɗaya tana da aminci.^[1] Wannan ya haɗa da waɗanda ke da cutar kanjamau amma ba tare da alamun bayyanar cututtuka ba.^[1] Matsakaicin sakamako na iya haɗawa da ciwon kai, ciwon tsoka, ciwo a wurin allurar, zazzabi, da rash.^[1] Rashin jituwa mai tsanani yana faruwa a cikin kimanin takwas a cikin miliyan, matsaloli masu tsanani na jijiyoyi suna faruwa a cikin kusan hudu a cikin miliyan ɗaya, kuma gazawar gabobin yana faruwa a kusan uku a cikin miliyan.^[1] Yana da aminci a ciki ciki kuma saboda haka ana ba da shawarar tsakanin waɗanda za a iya fallasa su.^[1] Bai kamata a ba da shi ga waɗanda ke da ƙarancin aikin rigakafi ba.^[4]

An fara amfani da allurar rigakafin zazzabi a shekarar 1938.^[5] Yana cikin Jerin Magunguna Masu Muhimmanci na Hukumar Lafiya ta Duniya.^[6][7] An yi allurar rigakafin ne daga kwayar cutar zazzabin rawaya.^[8] Wasu ƙasashe suna buƙatar takardar shaidar rigakafin zazzabin rawaya kafin shiga daga ƙasar da cutar ta zama ruwan dare.^[1][2]

1. ↑ ^{1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13} World Health Organization (July 2013). "Vaccines and vaccination against yellow fever. WHO position paper -- June 2013". Weekly Epidemiological Record. 88 (27): 269–283. hdl:10665/242089. PMID 23909008.
2. ↑ ^{2.0 2.1} "Yellow Fever Vaccine - an overview | ScienceDirect Topics". www.sciencedirect.com. Retrieved 30 April 2022.
3. ↑ Staples JE, Bocchini JA, Rubin L, Fischer M (June 2015). "Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015". MMWR. Morbidity and Mortality Weekly Report. 64 (23): 647–650. PMC 4584737. PMID 26086636.
4. ↑ "Yellow Fever Vaccine". Centers for Disease Control and Prevention (CDC). 13 December 2011. Archived from the original on 9 December 2015. Retrieved 15 December 2015.
5. ↑ Norrby E (November 2007). "Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine". The Journal of Experimental Medicine. 204 (12): 2779–2784. doi:10.1084/jem.20072290. PMC 2118520. PMID 18039952.
6. ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
7. ↑ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
8. ↑ World Health Organization (July 2013). "Vaccines and vaccination against yellow fever. WHO position paper -- June 2013". Weekly Epidemiological Record. 88 (27): 269–283. PMID 23909008. |hdl-access= requires |hdl= (help)